The Difference Between 503a and 503b Compounding Pharmacies

Article

Loyd Allen, Editor in Chief of the International Journal of Pharmaceutical Compounding, discusses the roles and limitations of each respective compounding classification.

Loyd Allen, Editor in Chief of the International Journal of Pharmaceutical Compounding, discusses the roles and limitations of each respective compounding classification.

Recent Videos
Related Content
FDA Approves Tirzepatide for Obstructive Sleep Apnea in Patients with Obesity

FDA Approves Tirzepatide for Obstructive Sleep Apnea in Patients with Obesity

Killian Meara
December 20th 2024
Article

Zepbound from Eli Lilly is the first and only prescription medicine approved by the FDA for adults with obstructive sleep apnea and obesity.

American Pharmacies: Powering the Profession Through Leadership

American Pharmacies: Powering the Profession Through Leadership

Brian Nowosielski
December 3rd 2024
Podcast

Drug Topics sat down with Laird Leavoy, President of American Pharmacies, to discuss the role leadership plays in the independent pharmacy industry.

CagriSema Demonstrates Statistically Significant, Superior Weight Loss Vs Placebo

CagriSema Demonstrates Statistically Significant, Superior Weight Loss Vs Placebo

Lauren Biscaldi, MS, Managing Editor
December 20th 2024
Article

Although the drug fell short of its 25% expected weight loss, results are still promising for people with overweight or obesity.

How Centralized Fulfillment is Making Pharmacy More Efficient

How Centralized Fulfillment is Making Pharmacy More Efficient

Brian Nowosielski
November 25th 2024
Podcast

Tom Utech, PharmD, CEO of iA, joined Drug Topics to discuss his company’s centralized pharmacy fulfillment solutions.

First Severe Case of Bird Flu Detected in Louisiana

First Severe Case of Bird Flu Detected in Louisiana

Brian Nowosielski
December 20th 2024
Article

Recent upticks of the bird flu virus in both dairy cattle and humans have also led to a state of emergency in California.

DOJ Lawsuit Alleges CVS Helped Fuel Opioid Epidemic Through Unlawful Opioid Prescriptions

DOJ Lawsuit Alleges CVS Helped Fuel Opioid Epidemic Through Unlawful Opioid Prescriptions

Lauren Biscaldi, MS, Managing Editor
December 19th 2024
Article

The lawsuit alleges that the company knowingly violated both the Controlled Substances Act and the False Claims Act.

© 2024 MJH Life Sciences

All rights reserved.